ChemicalBook > Product Catalog >Biochemical Engineering >Inhibitors >Metabolism >P450 (e.g. CYP17) inhibitor >Abiraterone
Abiraterone
- CAS No.
- 154229-19-3
- Chemical Name:
- Abiraterone
- Synonyms
- Cb-7598;7-Keto Abiraterone Acetate;(3β)-17-(3-Pyridinyl)androsta-5,16-dien-3-ol;Androsta-5,16-dien-3-ol, 17-(3-pyridinyl)-, (3beta)-;(3S,8R,9S,10R,13S,14S)-10,13-diMethyl-17-(pyridin-3-yl)-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol;CS-211;Abiron;Cb 7598;Abytron;Abitelon
- CBNumber:
- CB01320705
- Molecular Formula:
- C24H31NO
- Molecular Weight:
- 349.52
- MOL File:
- 154229-19-3.mol
- Modify Date:
- 2024/7/18 18:48:51
| Melting point | 227-228 °C(Solv: toluene (108-88-3)) |
|---|---|
| Boiling point | 500.2±50.0 °C(Predicted) |
| Density | 1.14±0.1 g/cm3(Predicted) |
| storage temp. | 2-8°C |
| solubility | Chloroform (Slightly), Methanol (Slightly) |
| form | Solid |
| pka | 14.71±0.70(Predicted) |
| color | White to Pale Yellow |
| CAS DataBase Reference | 154229-19-3 |
SAFETY
Risk and Safety Statements
| Symbol(GHS) |  GHS07 |
|---|---|
| Signal word | Warning |
| Hazard statements | H302-H315-H319-H332-H335 |
| Precautionary statements | P233-P260-P261-P264-P270-P271-P280-P301+P312-P302+P352-P304-P304+P340-P305+P351+P338-P312-P321-P330-P332+P313-P337+P313-P340-P362-P403-P403+P233-P405-P501 |
Abiraterone price More Price(2)
Abiraterone Chemical Properties,Uses,Production
Chemical Properties
White Solid
Uses
Abiraterone, a steroidal cytochrome P 450 17α-hydroxylase-17,20-lyase inhibitor (CYP17), is currently undergoing phase II clinical trials as a potential drug for the treatment of androgen-dependent pr ostate cancer.
Definition
ChEBI: A 3beta-sterol that is androsta-5,16-dien-3beta-ol substituted at position 17 by a 3-pyridyl group. Administered as the O-acetate, it is used for treatment of metastatic castrate-resistant prostate cance .
Abiraterone Preparation Products And Raw materials
Raw materials
Preparation Products
Global( 442)Suppliers
| Supplier | Tel | Country | ProdList | Advantage | Inquiry |
|---|---|---|---|---|---|
| AVD pharmaceuticals Pvt Ltd | +919860835260 | Pune, India | 102 | 58 | Inquiry |
| Anant Pharmaceuticals Pvt Ltd | +91-8550986868 +91-9485998001 | Haryana, India | 461 | 58 | Inquiry |
| Credas Labs Pvt Ltd | +91 9133918031 | Hyderabad, India | 119 | 58 | Inquiry |
| OPULENT PHARMA | +91-9106692785 +91-9106692785 | Gujarat, India | 479 | 58 | Inquiry |
| GLP Pharma Standards | +91 9866074638 | Hyderabad, India | 1644 | 58 | Inquiry |
| SAG Chem | +91-9819395336 +91-9819395336 | Mumbai, India | 17 | 58 | Inquiry |
| Aavyan Labs | +91-9652399498 +91-9652399498 | Telangana, India | 60 | 58 | Inquiry |
| KPS Chemicals And Pharmaceuticals | +91-9870076629 +91-8469484608 | Gujarat, India | 33 | 58 | Inquiry |
| Acebright (India) Pharma Pvt. Ltd. | 91-8110-415539 | Bangalore, India | 3 | 58 | Inquiry |
| KEKULE PHARMA LIMITED | +91-40-2373-3225 | New Delhi, India | 21 | 58 | Inquiry |
| Supplier | Advantage |
|---|---|
| AVD pharmaceuticals Pvt Ltd | 58 |
| Anant Pharmaceuticals Pvt Ltd | 58 |
| Credas Labs Pvt Ltd | 58 |
| OPULENT PHARMA | 58 |
| GLP Pharma Standards | 58 |
| SAG Chem | 58 |
| Aavyan Labs | 58 |
| KPS Chemicals And Pharmaceuticals | 58 |
| Acebright (India) Pharma Pvt. Ltd. | 58 |
| KEKULE PHARMA LIMITED | 58 |
Related articles
- Abiraterone: Therapeutic Target and Impact of Food on its Exposure
- Abiraterone targets CYP17A in CRPC, disrupting androgen synthesis. It inhibits unintended AR targets and requires fasting for ....
- Feb 22，2024
- Abiraterone: mechanism of action, pharmacokinetics and clinical applications
- Abiraterone inhibits androgen synthesis via CYP17A to treat mCRPC. Coadministered with prednisone, it improves survival outcom....
- Sep 4，2023
- Special precautions and Abiraterone of Abiraterone
- Abiraterone is used in combination with prednisone to treat a certain type of prostate cancer that has spread to other parts o....
- Nov 7，2019
154229-19-3(Abiraterone)Related Search:
abiraterone
Cb 7598
Unii-G819A456D0
Abiraterone(CB-7598)
17-(3-Pyridyl)androsta-5,16-dien-3beta-ol
Aberration
ABT
17-(3-pyridyl)androsta-5,16-dien-3β-ol
abiraterone
(3b)-17-(3-pyridinyl)-Androsta-5,16-dien-3-ol
Abiraterone(3b)-17-(3-pyridinyl)-Androsta-5,16-dien-3-ol )
(3,BETA) 17,(PYRIDIN-3-YL)ANDROSTA-5,16-DIEN-3-OL
(3beta)-17-(3-pyridinyl)-androsta-5,16-dien-3-ol
17-(3-pyridinyl)-(3β)-androsta-5,16-dien-3-ol
Abiraterone N-Oxide Impurity
Abiraterone, >=98%
3-epi-Abiraterone Acetate
Abiraterone Acetate Alpha-Epoxide
Abiraterone Acetate Beta-Epoxide
Abiraterone Acetate Epoxide N-Oxide
Acetyl Abiraterone
Prasteronyl Abiraterone
CB-7598;CB7598;CB 7598
BNKY019-AA03
Abiraterone (base)
(3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-(3-pyridyl)-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-ol
CS-211
Abiron
Abitelon
Abiraterone>
(1S,2R,5S,10R,11S,15S)-2,15-dimethyl-14-(pyridin-3-yl)tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-7,13-dien-5-ol
17-(Pyridin-3-yl)androsta-5,16-dien-3β-ol
Androsta-5,16-dien-3-ol, 17-(3-pyridinyl)-, (3β)-
Abiraterone USP/EP/BP
(3S,8R,9S,10R,13S,14S)-10,13-Dimethyl-17-(pyridin-3-yl)-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol? (Abiraterone Impurity)
17-(3-pyridyl)androsta-5,16-dien-3β-ol
AbirateroneQ: What is
Abiraterone Q: What is the CAS Number of
Abiraterone Q: What is the storage condition of
Abiraterone Q: What are the applications of
Abiraterone
Abiraterone / (3β)-17-(Pyridin-3-yl)- androsta-5,16-dien-3-ol
Androsta-5,16-dien-3-ol, 17-(3-pyridinyl)-, (3beta)-
Cb-7598
(3S,8R,9S,10R,13S,14S)-10,13-diMethyl-17-(pyridin-3-yl)-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol
(3β)-17-(3-Pyridinyl)androsta-5,16-dien-3-ol
7-Keto Abiraterone Acetate
(3β)-17-(3-Pyridinyl)androsta-5,16-dien-3-ol
154229-19-3
Abiraterone Raw Powder
Inhibitor,CB7598,Cytochrome P450,inhibit,CYPs,CB 7598,Abiraterone
Abitaternone Alcohol
Abytron
17-(3-Pyridinyl)-androsta-5,16-dien-3beta-ol
154229-19-3
154229-19-4
Inhibitor
Inhibitors
Intermediate of Abiraterone Acetate
Steroids
API
Intermediates & Fine Chemicals
Pharmaceuticals
154229-19-3